We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Birinci Basamak Sağlık Kuruluşlarına Başvuran Hastalardan Alınan Kan Örneklerinde İki Yıllık Hepatit ve HIV Seroprevalansı.
- Authors
Tuna, Duygu Kübra; Dicle, Yalçın; Aydın, Elif
- Abstract
Objective: Viral hepatitis and HIV are a global health problem causing acute and chronic infections. The aim of this study was to determine the HBsAg, Anti-HBs, Anti-HCV, anti-HAV IgG and Anti-HIV seropositivity rates in clinical samples sent from primary health care centers to Department of Van Public Health. Material and Method: In this study, data obtained from the clinical HBsAg, anti-HBS, anti-HCV, HAV IgG and anti-HIV seroprevalence samples between January 2016 and January 2018 in Van province and its surrounding were retrospectively evaluated. Serum samples were analyzed by Chemiluminescent Microparticle İmmunoassay (CMIA) using Siemens (Advia CP, USA). Chi-square test was used for statistical evaluation of serological data. Results: A total of 44509 patients were tested for HBsAg, 50183 patients for anti-HBs, 39552 patients for anti-HCV, 37671 patients for anti-HAV IgG and 35084 patients for anti- HIV tests. In this study, seropositivity rate was found as 1.66% in HBsAg, 30.6% in Anti-HBs, 0.27% in Anti-HCV, 48.67% in anti-HAV IgG and 0.005% in Anti-HIV. The highest anti-HBs seropositivity rate was found in patients who were under 15 years and between 15-24 years. Conclusion: When compared with the literature, generally HbsAg, anti HBs, anti-HCV, HAV IgG and anti-HIV seroprevalence were found lower than published studies. The most important reason for the low seropositivity rates in this study is that the majority of donors can be considered as the formation of healthy individuals applying to primary health care centers to obtain a health report.
- Publication
Van Tip Dergisi, 2021, Vol 28, Issue 3, p404
- ISSN
1300-2694
- Publication type
Article
- DOI
10.5505/vtd.2021.04468